ADAM17 anticorps (ADAM Metallopeptidase Domain 17) (C-Term)

Details for Product anti-ADAM17 Antibody No. ABIN4357504
Antigène
  • ADAM18
  • CD156B
  • CSVP
  • NISBD
  • TACE
  • CD156b
  • Tace
  • adam17
  • si:dkey-81b15.2
  • adam18
  • cd156b
  • csvp
  • tace
  • fc20b01
  • wu:fc20b01
  • zgc:63886
  • ADAM metallopeptidase domain 17
  • a disintegrin and metallopeptidase domain 17
  • ADAM metallopeptidase domain 17b
  • ADAM metallopeptidase domain 17 L homeolog
  • ADAM metallopeptidase domain 17a
  • ADAM17
  • Adam17
  • adam17b
  • adam17.L
  • adam17a
Épitope
C-Term
62
19
16
11
9
9
8
8
7
6
4
3
3
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
Reactivité
Humain, Souris, Rat (Rattus)
243
96
87
2
2
1
1
1
1
1
Hôte
Lapin
207
22
21
2
1
Clonalité
Polyclonal
Conjugué
Cet anticorp ADAM17 est non-conjugé
14
10
7
6
6
5
4
4
4
4
4
4
1
1
1
1
1
1
Application
Immunohistochemistry (IHC), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Western Blotting (WB)
195
121
45
39
25
14
11
11
10
7
5
3
2
1
1
1
Options
Immunogène Recombinant protein encompassing a sequence within the C-terminus region of human ADAM17. The exact sequence is proprietary.
Isotype IgG
Purification Immunogen affinity purified
Plasmids, Primers & others Plasmids, Primers & others ADAM17 products on genomics-online (e.g. as negative or positive controls)
Antigène
Autre désignation TACE/ADAM17 (ADAM17 Antibody Extrait)
Sujet Gene Symbol: ADAM17
Poids moléculaire Theoretical MW: 93 kDa
ID gène 6868
UniProt P78536
Pathways Signalisation Notch, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Response to Growth Hormone Stimulus
Indications d'application Western Blot 1:500-1:3000, Immunohistochemistry 1:100-1:1000, Immunohistochemistry-Paraffin 1:100-1:1000The observed molecular weight of the protein may vary from the listed predicted molecular weight due to post translational modifications, post translation cleavages, relative charges, and other experimental factors.
Commentaires

The antibodies are intended for use in vitro experiments only. Our antibodies have not been tested nor are recommended for use in vivo.

Restrictions For Research Use only
Format Liquid
Concentration 1 mg/mL
Buffer PBS ( pH 7.0) and 40 % Glycerol
Buffer contains: 0.01 % Thimerosal
Agent conservateur Thimerosal (Merthiolate)
Précaution d'utilisation This product contains Thimerosal (Merthiolate): a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Stock -80 °C,-20 °C
Stockage commentaire Aliquot and store at -20°C or -80°C. Avoid freeze-thaw cycles.
Images (Fournisseur)
Western Blotting (WB) image for anti-ADAM Metallopeptidase Domain 17 (ADAM17) (C-Term) antibody (ABIN4357504) Western Blot: TACE/ADAM17 Antibody , C-term diluted at 1:500.
Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)) image for anti-ADAM Metallopeptidase Domain 17 (ADAM17) (C-Term) antibody (ABIN4357504) Immunohistochemistry-Paraffin: TACE/ADAM17 Antibody - Human breast carcinoma dilutio...
Western Blotting (WB) image for anti-ADAM Metallopeptidase Domain 17 (ADAM17) (C-Term) antibody (ABIN4357504) Western Blot: TACE/ADAM17 Antibody , C-term diluted at 1:500.
Western Blotting (WB) image for anti-ADAM Metallopeptidase Domain 17 (ADAM17) (C-Term) antibody (ABIN4357504) Western Blot: TACE/ADAM17 Antibody , C-term diluted at 1:500. The HRP-conjugated anti...
Produit citée dans: Sharma, Bender, Zimmermann, Riesterer, Broggini-Tenzer, Pruschy: "Secretome Signature Identifies ADAM17 as Novel Target for Radiosensitization of Non-Small Cell Lung Cancer." dans: Clinical cancer research : an official journal of the American Association for Cancer Research, Vol. 22, Issue 17, pp. 4428-39, 2016 (PubMed). (Échantillon (espèces): Human). Détails: Western Blotting,Immunohistochemistry (Paraffin-embedded Sections)

Avez-vous cherché autre chose?